德克斯梅德托米丁:基于FDA不良事件报告系统数据库的现实安全分析
Yichun Shuai1, Zhe Chen2, Qiaoqian Wan1
1Department of Anesthesiology, Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Frontiers in pharmacology
|September 9, 2024
概括
这项研究分析了FDA对德克斯梅德托米丁的不良事件报告,确定了常见和新的安全问题,如心脏病和无味糖尿病,以改善临床使用.
科学领域:
- 药物监督 药物监督 药物监督
- 临床药理学 临床药理学
- 药品安全 药品安全
背景情况:
- 德克斯梅德托米丁 (Dexmedetomidine) 广泛用于镇静和麻醉.
- 了解其全面的安全概况对于临床应用至关重要.
- 美国食品和药物管理局 (FDA) 的不良事件报告系统 (FAERS) 数据库为市场后药物监测提供了宝贵的资源.
研究的目的:
- 使用FAERS数据分析德克斯梅德托米丁的安全性.
- 为了确定与德克斯米德米丁相关的已知和以前未报告的不良事件.
- 为Dexmedetomidine的安全临床使用提供基于证据的指导.
主要方法:
- 利用了来自FAERS数据库的数据 (2004年第一季度 - 2023年第三季度).
- 采用了统计方法,包括报告几率比率 (ROR),比例报告比率 (PRR) 和贝叶斯信任传播神经网络 (BCPNN).
- 分析了1910年的报告,确定了892个首选术语,包括52个新术语.
主要成果:
- 常见的不良事件包括胸肌梗塞,心脏骤停,低血压和激动.
- 心脏疾病成为最常见的高信号强度的器官系统类别.
- 识别了具有高信号强度的新型不良事件,如急性运动轴突神经病变和软虹膜综合征.
结论:
- 这项药监测研究成功地确定了德克斯梅德托米丁的已知和新的不良事件.
- 这些发现强调了监测特定不良事件的重要性,包括那些未在药物插件中列出的不良事件.
- 这项研究提供了关键的见解,以提高临床警,并减轻与德克斯梅德托米丁治疗相关的风险.
更多相关视频
03:49Author Spotlight: Optimizing EAS with Long Electrodes for Enhanced Cochlear Coverage and Hearing Preservation
Published on: October 11, 2024
752
07:54Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
19.7K
相关概念视频
Pharmacovigilance
788
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
788
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Parenteral Anesthetics: Overview
111
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
111
Skeletal Muscle Relaxants: Adverse Effects
348
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
348
Sedatives and Hypnotics Drugs: Miscellaneous Agents
159
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
159
Antiepileptic Drugs: Potassium Channel Activators
149
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
149
